NEWS legal form changed ByOncoscience 22. August 201717. July 2025 We are now Oncoscience GmbH. Managing directors are Dr. Dirk Reuter, Dr. Budhi Simon and Robert Ellerson. Ähnliche Beiträge
Allgemein | NEWS Specific Pharma A/S and Oncoscience GmbH launch a Named Patient Program for the treatment of cancer with nimotuzumab. ByOncoscience 6. November 202017. July 2025
NEWS YM BioSciences partner Oncoscience AG reports update of pediatric brain cancer data ByOncoscience 30. September 200517. July 2025
NEWS YM BioSciences and Oncoscience Report Response Rate of 35.3% in Pediatric Glioma ByOncoscience 1. March 200517. July 2025
NEWS Mawdsleys and Oncoscience launch a Named Patient Program for CIMAher® (Nimotuzumab) in the U.K. and Ireland ByOncoscience 3. October 201817. July 2025
NEWS YM Biosciences and Oncoscience AG achieve clinical milestone ByOncoscience 10. January 200517. July 2025
